转录因子E2F3激活CDC25B以调节DNA损伤并促进胃腺癌中的线粒激素耐药性
相关实验视频
Updated: Jul 6, 2025

04:20
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
955
Xiaoming Pan1, Chaobo Xu1, Guoxiong Cheng1
1Department of Gastrointestinal Surgery, Lishui People's Hospital, No.15 Dazhong Street, Liandu District, Lishui, Zhejiang Province, 323000, China.
Molecular biology reports
|January 9, 2024
概括
通过调节DNA损伤,E2F3/CDC25B途径在胃腺癌 (STAD) 中促进线粒激素耐药性. 这一发现为STAD治疗提供了一个新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- CDC25B是一种细胞循环调节剂和在各种瘤中高度表达的瘤基因.
- 这项研究调查了CDC25B在胃腺癌 (STAD) 中的线粒激素抵抗中的作用.
研究的目的:
- 阐明CDC25B对STAD中线粒激素耐药性的影响.
- 探索涉及E2F3和DNA损伤的潜在机制.
主要方法:
- 在STAD中对CDC25B和E2F3表达和IC50值进行生物信息学分析.
- qRT-PCR,MTT测试和彗星测试用于评估基因表达,细胞活力和DNA损伤.
- 双化酶和ChIP测试验证了E2F3-CDC25B的调控关系.
主要成果:
- 在STAD中,CDC25B和E2F3的表达很高,而CDC25B与更高的IC50值有关.
- E2F3通过转录激活了CDC25B,通过调节DNA损伤来促进线粒激素抵抗.
- E2F3敲击抑制了抵抗,但CDC25B过度表达逆转了这种效应.
结论:
- 确定了一种新的E2F3/CDC25B信号通路,可以调解DNA损伤并促进STAD中的线粒激素耐药性.
- 这一途径代表了STAD治疗的潜在治疗标.
更多相关视频
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Electron Transport Chain: Complex I and II
13.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.4K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K

